Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
about
Dendrimer advances for the central nervous system delivery of therapeuticsInfluence of core and maltose surface modification of PEIs on their interaction with plasma proteins-Human serum albumin and lysozyme.The amyloid beta peptide: a chemist's perspective. Role in Alzheimer's and fibrillization.Inhibition of amyloid-β aggregation in Alzheimer's disease.Nanomaterials for reducing amyloid cytotoxicity.Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications.Dendrimers as nonviral vectors in dendritic cell-based immunotherapies against human immunodeficiency virus: steps toward their clinical evaluation.Decreasing amyloid toxicity through an increased rate of aggregation.Glycodendrimer PPI as a Potential Drug in Chronic Lymphocytic Leukaemia. The Influence of Glycodendrimer on Apoptosis in In Vitro B-CLL Cells Defined by Microarrays.Systems-level thinking for nanoparticle-mediated therapeutic delivery to neurological diseases.Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges.Toxicity and proapoptotic activity of poly(propylene imine) glycodendrimers in vitro: considering their contrary potential as biocompatible entity and drug molecule in cancer.Nanobiomaterials' applications in neurodegenerative diseases.Nanotechnological strategies for nerve growth factor delivery: Therapeutic implications in Alzheimer's disease.Influence of surface groups on poly(propylene imine) dendrimers antiprion activity.Molecular properties of lysine dendrimers and their interactions with Aβ-peptides and neuronal cells.Development of water-soluble polyanionic carbosilane dendrimers as novel and highly potent topical anti-HIV-2 microbicides.Supramolecular glycodendrimer-based hybrid drugs.Stability of dendriplexes formed by anti-HIV genetic material and poly(propylene imine) dendrimers in the presence of glucosaminoglycans.Glycodendrimers as new tools in the search for effective anti-HIV DC-based immunotherapies.Star Polymers Reduce Islet Amyloid Polypeptide Toxicity via Accelerated Amyloid Aggregation.Differentiating prion strains using dendrimers.Effect of poly(propylene imine) glycodendrimers on beta-amyloid aggregation in vitro and in APP/PS1 transgenic mice, as a model of brain amyloid deposition and Alzheimer's disease.Core-and-surface-functionalized polyphenylene dendrimers for solution-processed, pure-blue light-emitting diodes through surface-to-core energy transfer.Interactions of dendritic glycopolymer with erythrocytes, red blood cell ghosts and membrane enzymes.The influence of maltotriose-modified poly(propylene imine) dendrimers on the chronic lymphocytic leukemia cells in vitro: dense shell G4 PPI.Influence of fourth generation poly(propyleneimine) dendrimers on blood cells.Dendritic Glycopolymer as Drug Delivery System for Proteasome Inhibitor Bortezomib in a Calcium Phosphate Bone Cement: First Steps Toward a Local Therapy of Osteolytic Bone Lesions.Synthesis of G0 aminopolyol and aminosugar dendrimers, controlled by NMR and MALDI TOF mass spectrometry.The influence of maltose modified poly(propylene imine) dendrimers on hen egg white lysozyme structure and thermal stabilityDendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful NanomedicineAmino acid modified hyperbranched poly(ethylene imine) with disaccharide decoration as anionic core–shell architecture: Influence of the pH and molecular architecture on solution behaviourGlycopolymer Polyelectrolyte Multilayers Composed of Heparin and Maltose-Modified Poly(ethylene imine) as a Strong/Weak Polyelectrolyte System for Future Drug Delivery Coatings: Influence of pH and Sugar Architecture on Growth of Multilayers and MultInteraction study between maltose-modified PPI dendrimers and lipidic model membranesReversed Hexagonal Lyotropic Liquid-Crystal and Open-Shell Glycodendrimers as Potential Vehicles for Sustained Release of Sodium DiclofenacFabricating pH-Stable and Swellable Very Thin Hyperbranched Poly(ethylene imine)-Oligosaccharide Films Fabricated Without Precoating: First View on Protein AdsorptionGenotoxicity of poly(propylene imine) dendrimersInternalization and Intracellular Trafficking of Poly(propylene imine) Glycodendrimers with Maltose Shell in Melanoma CellsSelf-assembly of poly(propylene imine) glycodendrimers: role of aromatic interactions in the formation of necklace- and donut-like nanostructuresMultivalent interacting glycodendrimer to prevent amyloid-peptide fibril formation induced by Cu(II): A multidisciplinary approach
P2860
Q26828423-227853C3-401F-4EDD-B88E-0C6F22B74C87Q30397174-470b00c8-4865-4472-84db-a1088c396294Q34289101-1d78c55c-449a-0a0a-76b4-e388ace5e414Q34742941-e8fd3dd2-4e03-254e-733d-f52a0860c8ceQ38110699-22C34A2C-5481-406B-A73F-71BE1293FDD3Q38292341-07241621-9A3D-4CA9-A42A-84417B1B5786Q38296086-0F8FBFBF-18E4-4CA2-86AF-3CBB397A58CDQ38725951-8B4CADEA-619D-462B-9242-E15146FE7E48Q38761549-56a627e5-4259-0f08-cbfa-341f5537ac89Q38937398-6AA54D68-AEA0-4712-92CF-0E67492E1B17Q39020937-961727e6-42d7-e990-1138-9bdb5380c9a9Q39041260-f27cfb5a-4355-6269-30e8-4d77342f4ccaQ39126802-6AF81C66-FC6F-4081-A921-C6EA81C0A678Q39205555-b1b370fb-4cb5-fe95-8672-730153e31c78Q39227337-e48cf8c8-4e2c-5b36-1817-9c5a13e67e25Q39266594-fac59c38-477e-16cd-4490-d66d9b878309Q41051936-958B2A8B-059A-4615-BEA5-F8BBCA30A047Q42184508-831eed36-46f3-e56c-7d50-0ecc59d4f51eQ42678907-42b44799-4328-1840-0ceb-e514d07d30d2Q46634962-0798252f-40cc-368e-fccc-836825bce066Q47158681-545EB196-F3EB-4F8B-B71E-4E4D1E95BD22Q48278342-C442AA96-589D-4262-92B4-7CEC0052BB1BQ49076009-364c8433-47fe-7cc9-16d6-7d8689c5160eQ50221372-1C007E7C-2DA8-4930-992C-F1D7CB7634D2Q50280311-13507193-4798-feca-b65e-92f10678a07dQ50491602-74d61029-4544-e798-57cc-5e50ac59d60cQ50510408-C7E7B551-9B33-4261-B36A-142FEB2E8AF1Q53675025-71394F40-7CE3-4E5B-B07F-DBCBD9FCBCDCQ55210306-08726376-ED7E-4D55-92DF-644B825DD337Q57275122-c443ea50-483b-6360-e9fe-fc68e8a18ecaQ57556323-D5F8765B-FC7D-4418-B4F3-0631744A5A43Q57776963-a18c65f6-4f30-990e-e6ee-1af60eea7698Q57776994-B4DDBDF8-5FC6-4FE9-AEF5-A286EE1D11FEQ57777009-af5b53da-4bc8-b86f-535a-d8618e086a43Q57777179-f4755388-4b61-4bce-68d2-ab8c69561273Q57777294-E6EC1D88-CEA9-421D-B072-2A98EF3AC608Q57777308-D4FBF849-6897-454C-9AEE-78E3895B731DQ57777323-09a133ea-49e3-17dc-a5bd-650b358018a5Q57777362-95F2DBC7-3542-4996-8707-C86C1F339264Q59438762-2e71160a-49af-d1a6-659a-03c5d794c066
P2860
Dense shell glycodendrimers as potential nontoxic anti-amyloidogenic agents in Alzheimer's disease. Amyloid-dendrimer aggregates morphology and cell toxicity.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Dense shell glycodendrimers as ...... morphology and cell toxicity.
@en
Dense shell glycodendrimers as ...... morphology and cell toxicity.
@nl
type
label
Dense shell glycodendrimers as ...... morphology and cell toxicity.
@en
Dense shell glycodendrimers as ...... morphology and cell toxicity.
@nl
prefLabel
Dense shell glycodendrimers as ...... morphology and cell toxicity.
@en
Dense shell glycodendrimers as ...... morphology and cell toxicity.
@nl
P50
P356
P1433
P1476
Dense shell glycodendrimers as ...... morphology and cell toxicity.
@en
P304
P356
10.1021/BM2008636
P577
2011-10-14T00:00:00Z